# HB Ventures

> HB Ventures is a VC fund in Gaobeidian backing Biotechnology, Health Care and ISP. See 9 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Gaobeidian, China
- Total investments: 9
- Last investment: Mar 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: http://linkedin.com/company/hb-ventures
- Website: http://www.hb-ventures.net

HB Ventures is a VC fund in Gaobeidian focused on Biotechnology and Health Care. HB Ventures a technology focused venture capital firm led by successful entrepreneurs, operators and bankers with strong technical and finance background as well as affiliation with leading Chinese e-commerce conglomerates. We have offices in Beijing, Bangkok and Hong Kong.We support early-stage companies in Greater China, South East Asia aswell as the United States with technological innovation in Data Technologies that can be applied to new retail, media, education, healthcare, biotech, real estate and finance.We adopt a thorough and disciplined investment approach focusing on innovative companies with strong, reliable and committed management team. We partner with entrepreneurs who aim to create value but not short term optimization.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 44% |
| Health Care | 2 | 22% |
| ISP | 1 | 11% |
| Mobile | 1 | 11% |
| Medical | 1 | 11% |

22 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 2 | 22% |
| Venture - Series Unknown | 2 | 22% |
| Series A | 1 | 11% |
| Series B | 1 | 11% |
| Series D | 1 | 11% |

7 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 7 | 78% |
| United States | 2 | 22% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Zhongke Yichuang | Zhongke Yichuang focuses on the development of automotive chips, power semiconductors and new energy vehicle controller systems. |  | Series A | Mar 20, 2023 |  |
| Meidong Huicheng | Meidong Huicheng is a platform for intelligent manufacturing of laboratory automation equipment and consumables. |  | Venture - Series Unknown | Jan 18, 2023 |  |
| Yizhu Technology | Yizhu Technology is a software company that specializes in AI computing power, engineering and consulting for storage data. |  | Venture - Series Unknown | Jan 01, 2023 |  |
| Leto Laboratories | Leto Laboratories is a manufacturer of protein products. | $14.5M | Series C | Dec 31, 2022 |  |
| Laekna Therapeutics | Laekna Therapeutics is a startup biotech company focusing on innovative drug discovery and development. Targeting large unmet medical needs, Laekna is dedicated to developing new therapies for cancer and liver diseases. | $61M | Series D | May 18, 2022 |  |
| Pillar Biosciences | Pillar Biosciences is prized with its patent-pending targeted sequencing technology platform and a proprietary data analysis toolkit, which achieves high sensitivity and specificity with clinical samples. The platform provides a fast, simple and affordable targeted sequencing method for NGS-based oncology testing. The start-up has also released itsbeta version of Lung & Colon Cancer Somatic Mutation Panel and BRCA1 & BRCA2 Germline Mutation Panel to cancer centers and clinical testing companies in the US and China for validation studies.The company was founded in 2014 and is headquartered in Natick, Massachusetts. | $29.7M | Series C | May 12, 2020 |  |
| Chengdu Zhongweida Xinko Technology | Chengdu Zhongweida Xinko Technology is an IT firm that specializes in quantum computing and control technology products. |  |  | Jan 01, 2020 |  |
| Changyi | Changyi is a mobile internet service provider based around Tencent Ecosystem. |  | Series B | Mar 01, 2019 |  |
| QuatRx Pharmaceuticals | QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds in the areas of endocrine, metabolic, and cardiovascular therapeutics.QuatRx Pharmaceuticals Company was founded in 2000 and is based in Ann Arbor, Michigan. | $44M | Series E | May 22, 2007 |  |

9 of 9 investments shown.

## Co-investors
- [CMG-SDIC Capital Management](https://shizune.co/investors/profile/cmg-sdic-capital-management) — VC Fund, 1 deal together
- [CS Capital](https://shizune.co/investors/profile/cs-capital) — VC Fund, 1 deal together
- [Granary Capital](https://shizune.co/investors/profile/granary-capital) — VC Fund, 1 deal together
- [Hercules Capital](https://shizune.co/investors/profile/herculescapital) — VC Fund, 1 deal together
- [Hibiscus Capital Management](https://shizune.co/investors/profile/hibiscus-capital-management) — VC Fund, 1 deal together
- [Infinity Capital](https://shizune.co/investors/profile/infinity-capital-ea3c) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does HB Ventures invest in?

HB Ventures invests primarily in Biotechnology, Health Care and ISP startups, most often at Series C and Venture - Series Unknown stage. Most of the 9 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did HB Ventures last invest?

The most recent investment recorded for HB Ventures closed in Mar 2023. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co